Q fever following bone marrow transplantation
1Department of Haematology, Charing Cross and Westminster Medical School, London, UK.
Abstract:
We describe a patient who developed an acute febrile illness 85 days after receiving an allogeneic bone marrow transplant for acute myeloid leukaemia. Serological investigation indicated the cause to be Q fever. The patient was receiving concurrent immunosuppressive therapy for graft-versus-host disease (GVHD). Coxiella burnetii should be added to the list of organisms which may complicate bone marrow transplantation. This case also provides further evidence to support an association between immunocompromised conditions and the development of Q fever.
Insights
A bone marrow transplant patient developed Q fever, a serious infection caused by Coxiella burnetii. This highlights the risk of Q fever in immunocompromised individuals post-transplant.
Area of Science:
- Infectious Diseases
- Hematology
- Transplantation Immunology
Background:
- Allogeneic bone marrow transplantation is a life-saving procedure for hematologic malignancies like acute myeloid leukemia.
- Patients undergoing transplantation often require immunosuppressive therapy to prevent graft-versus-host disease (GVHD).
- Immunocompromised states increase susceptibility to opportunistic infections.
Observation:
- A patient presented with acute febrile illness 85 days post-allogeneic bone marrow transplant for acute myeloid leukemia.
- The patient was concurrently receiving immunosuppressive therapy for GVHD.
- Serological tests confirmed the diagnosis of Q fever.
Findings:
- Coxiella burnetii infection (Q fever) was identified as the cause of the febrile illness.
- This case demonstrates Q fever as a potential complication following bone marrow transplantation.
- The findings support a link between immunocompromised conditions and Q fever development.
Implications:
- Coxiella burnetii should be considered in the differential diagnosis of febrile illnesses in bone marrow transplant recipients.
- This case underscores the importance of vigilant monitoring for infections in immunocompromised patients.
- Further research may elucidate specific risk factors and optimal management strategies for Q fever in transplant populations.
Related Concept Videos
Methods of reducing fever
Pharmacological Methods of Reducing Fever:
Patterns of Fever
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Rocky Mountain Spotted Fever
Yellow Fever


